Beam Therapeutics, Inc. (BEAM)
24.50
+0.11
(+0.45%)
USD |
NASDAQ |
Oct 02, 16:00
24.50
0.00 (0.00%)
Pre-Market: 20:00
Beam Therapeutics Net Income (Quarterly) : -122.68M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.68M |
| March 31, 2026 | -94.32M |
| December 31, 2025 | 244.30M |
| September 30, 2025 | -112.73M |
| June 30, 2025 | -102.14M |
| March 31, 2025 | -108.33M |
| December 31, 2024 | -90.35M |
| September 30, 2024 | -96.67M |
| June 30, 2024 | -91.05M |
| March 31, 2024 | -98.67M |
| December 31, 2023 | 142.80M |
| September 30, 2023 | -96.09M |
| June 30, 2023 | -82.78M |
| March 31, 2023 | -96.46M |
| December 31, 2022 | -38.35M |
| September 30, 2022 | -109.58M |
| Date | Value |
|---|---|
| June 30, 2022 | -71.95M |
| March 31, 2022 | -69.21M |
| December 31, 2021 | -64.71M |
| September 30, 2021 | -28.12M |
| June 30, 2021 | -76.25M |
| March 31, 2021 | -201.56M |
| December 31, 2020 | -95.46M |
| September 30, 2020 | -34.45M |
| June 30, 2020 | -34.22M |
| March 31, 2020 | -30.46M |
| December 31, 2019 | -27.85M |
| September 30, 2019 | -19.00M |
| June 30, 2019 | -17.86M |
| March 31, 2019 | -13.61M |
| December 31, 2018 | -25.19M |
| September 30, 2018 | -71.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -106.63M |
| Twist Bioscience Corp. | -35.05M |
| Prime Medicine, Inc. | -42.11M |
| Q32 Bio, Inc. | -8.946M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.49M |
| Total Expenses (Quarterly) | 123.17M |
| EPS Diluted (Quarterly) | -1.176 |
| Enterprise Value | 1.624B |
| Gross Profit Margin (Quarterly) | -1.00K% |
| Profit Margin (Quarterly) | -25.04K% |
| Earnings Yield | -3.51% |
| Normalized Earnings Yield | -3.461 |